US DEA reschedules GW Pharmaceuticals’ Epidiolex to Schedule V
EPIDIOLEX, which was approved by the U.S. Food and Drug Administration (FDA) on June 25, 2018 for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet
EPIDIOLEX, which was approved by the U.S. Food and Drug Administration (FDA) on June 25, 2018 for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) or Dravet
The BLA for SB5 was submitted by Samsung Bioepis in July 2018. The BLA for SB5 was based on data derived from a randomized, double-blind 52-week Phase 3
Ibnsina Pharma, a major healthcare solutions provider in the region, has been growing steadily through supply chain services, importation, and distribution of health care products in the private
Also known as radiation sickness or radiation toxicity, acute radiation syndrome is a potentially life-threatening condition, caused by exposure to high radiation levels following a nuclear accident or
Durvalumab reduced the risk of death by 32% in comparison to standard of care in the late-stage trial. In the durvalumab arm, the median time to death or
Farxiga was assessed in a trial, dubbed DECLARE-TIMI 58, in more than 17,000 T2D adult patients having multiple CV risk factors or established CV condition. In the five-year
Symbiosis recently hosted a successful inspection by the FDA for the aseptic manufacture of viral vector products for commercial supply into the U.S market at its GMP manufacturing
The expanded indication for the once-daily single inhaler triple therapy would enable use by patients not adequately treated by a long-acting muscarinic receptor antagonist (LAMA) and long-acting β2-agonist
THRUCOOL offers dedicated cold chain services to safeguard the integrity of pharmaceutical and healthcare shipments during air transportation. These include priority uplift and handling, quick ramp transfers at
Grifols is a global healthcare company based in Spain. Biotest US is a healthcare company based in Florida. According to the complaint, which was announced in August 2018,